CTI BIOPHARMA Trademark

Trademark Overview

On Tuesday, January 29, 2019, a trademark application was filed for CTI BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the CTI BIOPHARMA trademark a serial number of 88280950. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 5, 2022. This trademark is owned by CTI Biopharma Corp.. The CTI BIOPHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations used for the treatment of cancer; and pharmaceutical preparations used for the treatment of immunological and inflammatory diseases, infections secondary to the oncologic disease, and the management of pain accompanying either the disease process or the associated treatment regimens
cti biopharma

General Information

Serial Number88280950
Word MarkCTI BIOPHARMA
Filing DateTuesday, January 29, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 5, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 4, 2019

Trademark Statements

Description of MarkThe mark consists of a stylized image of a stick figure design to the left hand side of the wording "CTI BIOPHARMA".
Goods and ServicesPharmaceutical preparations used for the treatment of cancer; and pharmaceutical preparations used for the treatment of immunological and inflammatory diseases, infections secondary to the oncologic disease, and the management of pain accompanying either the disease process or the associated treatment regimens
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"BIOPHARMA"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 21, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCTI Biopharma Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98121
Party NameCTI Biopharma Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98121

Trademark Events

Event DateEvent Description
Tuesday, September 6, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 5, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, January 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 18, 2022SOU EXTENSION 5 GRANTED
Friday, January 14, 2022SOU EXTENSION 5 FILED
Friday, January 14, 2022SOU TEAS EXTENSION RECEIVED
Thursday, July 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 13, 2021SOU EXTENSION 4 GRANTED
Tuesday, July 13, 2021SOU EXTENSION 4 FILED
Tuesday, July 13, 2021SOU TEAS EXTENSION RECEIVED
Thursday, January 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 19, 2021SOU EXTENSION 3 GRANTED
Tuesday, January 19, 2021SOU EXTENSION 3 FILED
Tuesday, January 19, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, July 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 6, 2020SOU EXTENSION 2 GRANTED
Monday, July 6, 2020SOU EXTENSION 2 FILED
Monday, July 6, 2020SOU TEAS EXTENSION RECEIVED
Thursday, June 18, 2020REVIEW OF CORRESPONDENCE COMPLETE
Wednesday, June 17, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 6, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 6, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 6, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, May 6, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 6, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 6, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, December 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 17, 2019SOU EXTENSION 1 GRANTED
Tuesday, December 17, 2019SOU EXTENSION 1 FILED
Tuesday, December 17, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, July 30, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 4, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 4, 2019PUBLISHED FOR OPPOSITION
Wednesday, May 15, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 25, 2019ASSIGNED TO LIE
Wednesday, April 10, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 10, 2019EXAMINER'S AMENDMENT ENTERED
Wednesday, April 10, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 10, 2019EXAMINERS AMENDMENT E-MAILED
Wednesday, April 10, 2019EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 10, 2019ASSIGNED TO EXAMINER
Thursday, March 21, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, February 21, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 1, 2019NEW APPLICATION ENTERED

Related Keywords

biopharma treatment disease preparations used pharmaceutical accompanying pain associated regimens management